A Map View Of US Biosimilar Uptake

Texas comes out on top for biosimilar uptake, but how do the other US states compare? Geographical data can pinpoint which states are embracing biosimilars, and which have a way to go.   

USA Map
• Source: Shutterstock

With policymakers and industry stakeholders increasingly focused on the cost savings opportunities tied to biosimilars, a Health Affairs study sheds light on some of the factors that influence uptake of these near-copies of pricey biologic medications.

Among almost 200,000 commercial and Medicare Advantage enrollees who newly initiated one of seven biologic drugs with available biosimilar versions...

More from Market Access

More from In Vivo